|
|
 Previous Article | Table of Contents | Next Article 
Blood, 15 April 2002, Vol. 99, No. 8, pp. 3027-3032
TRANSPLANTATION
The DBY gene codes for an HLA-DQ5-restricted human
male-specific minor histocompatibility antigen involved in
graft-versus-host disease
Mario H. J. Vogt,
Joost W. van den Muijsenberg,
Els Goulmy,
Eric Spierings,
Petra Kluck,
Michel G. Kester,
Ronald A. van
Soest,
Jan W. Drijfhout,
Roel Willemze, and
J. H. Frederik Falkenburg
From the Departments of Hematology, and
Immunohematology and Blood Transfusion, Leiden University
Medical Center, The Netherlands.
Graft rejection or graft-versus-host (GVH) disease after
HLA-identical stem cell transplantation is the result of recognition of
minor histocompatibility antigens (mHags) by immunocompetent T
lymphocytes from recipient or donor origin, respectively. Cytolytic T
lymphocyte (CTL) clones can be isolated during graft rejection and GVH
disease to identify mHags and their corresponding genes. Thus far, all
human mHags identified appeared to be HLA class I-restricted. Here, we
report the characterization of the first human HLA class II-restricted
sex-linked mHag involved in GVH disease. Previously, we isolated an
HLA-DQ5-restricted CD4+ CTL clone from a male patient with
chronic myeloid leukemia who developed acute GVH disease grade III-IV
after transplantation of HLA genotypically identical female stem cells.
Using a panel of female HLA-DQ5+ EBV cells that we stably
transfected with Y chromosome-specific genes, we determined that the
HLA class II male-specific mHag (H-Y) was encoded by the Y
chromosome-specific gene DBY. The H-Y epitope was
localized in the DBY protein using female HLA-DQ5+
peripheral blood mononuclear cells loaded with DBY protein fragments. The minimal peptide sequence leading to maximal recognition by the
specific HLA-DQ5-restricted CTL clone was characterized as the
12-amino acid sequence HIENFSDIDMGE. Although the epitope differed by
3 amino acids from its X-homolog DBX, only 2 polymorphisms were shown
to be essential for recognition by the CTL clone.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
A. N. Stumpf, E. D. van der Meijden, C. A. M. van Bergen, R. Willemze, J. H. F. Falkenburg, and M. Griffioen
Identification of 4 new HLA-DR-restricted minor histocompatibility antigens as hematopoietic targets in antitumor immunity
Blood,
October 22, 2009;
114(17):
3684 - 3692.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. V. Rosinski, N. Fujii, J. K. Mito, K. K. W. Koo, S. M. Xuereb, O. Sala-Torra, J. S. Gibbs, J. P. Radich, Y. Akatsuka, B. J. Van den Eynde, et al.
DDX3Y encodes a class I MHC-restricted H-Y antigen that is expressed in leukemic stem cells
Blood,
May 1, 2008;
111(9):
4817 - 4826.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Griffioen, E. D. van der Meijden, E. H. Slager, M. W. Honders, C. E. Rutten, S. A. P. van Luxemburg-Heijs, P. A. von dem Borne, J. J. van Rood, R. Willemze, and J. H. F. Falkenburg
Identification of phosphatidylinositol 4-kinase type II {beta} as HLA class II-restricted target in graft versus leukemia reactivity
PNAS,
March 11, 2008;
105(10):
3837 - 3842.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. H. M. Heemskerk, R. S. Hagedoorn, M. A. W. G. van der Hoorn, L. T. van der Veken, M. Hoogeboom, M. G. D. Kester, R. Willemze, and J. H. F. Falkenburg
Efficiency of T-cell receptor expression in dual-specific T cells is controlled by the intrinsic qualities of the TCR chains within the TCR-CD3 complex
Blood,
January 1, 2007;
109(1):
235 - 243.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. A. Copelan
Hematopoietic stem-cell transplantation.
N. Engl. J. Med.,
April 27, 2006;
354(17):
1813 - 1826.
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. T. van der Veken, R. S. Hagedoorn, M. M. van Loenen, R. Willemze, J.H. F. Falkenburg, and M. H.M. Heemskerk
{alpha}{beta} T-Cell Receptor Engineered {gamma}{delta} T Cells Mediate Effective Antileukemic Reactivity.
Cancer Res.,
March 15, 2006;
66(6):
3331 - 3337.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. M. Kloosterboer, S. A. P. van Luxemburg-Heijs, R. A. van Soest, H. M. E. van Egmond, R. Willemze, and J. H. F. Falkenburg
Up-regulated expression in nonhematopoietic tissues of the BCL2A1-derived minor histocompatibility antigens in response to inflammatory cytokines: relevance for allogeneic immunotherapy of leukemia
Blood,
December 1, 2005;
106(12):
3955 - 3957.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. B. Miklos, H. T. Kim, K. H. Miller, L. Guo, E. Zorn, S. J. Lee, E. P. Hochberg, C. J. Wu, E. P. Alyea, C. Cutler, et al.
Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission
Blood,
April 1, 2005;
105(7):
2973 - 2978.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Ivanov, T. Aarts, S. Hol, A. Doornenbal, A. Hagenbeek, E. Petersen, and S. Ebeling
Identification of a 40S Ribosomal Protein S4-Derived H-Y Epitope Able to Elicit a Lymphoblast-Specific Cytotoxic T Lymphocyte Response
Clin. Cancer Res.,
March 1, 2005;
11(5):
1694 - 1703.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Torikai, Y. Akatsuka, M. Miyazaki, E. H. Warren III, T. Oba, K. Tsujimura, K. Motoyoshi, Y. Morishima, Y. Kodera, K. Kuzushima, et al.
A Novel HLA-A*3303-Restricted Minor Histocompatibility Antigen Encoded by an Unconventional Open Reading Frame of Human TMSB4Y Gene
J. Immunol.,
December 1, 2004;
173(11):
7046 - 7054.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J.-G. Chai, E. James, H. Dewchand, E. Simpson, and D. Scott
Transplantation tolerance induced by intranasal administration of HY peptides
Blood,
May 15, 2004;
103(10):
3951 - 3959.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Zorn, D. B. Miklos, B. H. Floyd, A. Mattes-Ritz, L. Guo, R. J. Soiffer, J. H. Antin, and J. Ritz
Minor Histocompatibility Antigen DBY Elicits a Coordinated B and T Cell Response after Allogeneic Stem Cell Transplantation
J. Exp. Med.,
April 19, 2004;
199(8):
1133 - 1142.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. S. B. Randolph, T. A. Gooley, E. H. Warren, F. R. Appelbaum, and S. R. Riddell
Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants
Blood,
January 1, 2004;
103(1):
347 - 352.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. B. Miklos, H. T. Kim, E. Zorn, E. P. Hochberg, L. Guo, A. Mattes-Ritz, S. Viatte, R. J. Soiffer, J. H. Antin, and J. Ritz
Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors
Blood,
January 1, 2004;
103(1):
353 - 359.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Weber, C. Lange, W. Gunther, M. Franz, E. Kremmer, and H.-J. Kolb
Minor Histocompatibility Antigens on Canine Hemopoietic Progenitor Cells
J. Immunol.,
June 15, 2003;
170(12):
5861 - 5868.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Akatsuka, T. Nishida, E. Kondo, M. Miyazaki, H. Taji, H. Iida, K. Tsujimura, M. Yazaki, T. Naoe, Y. Morishima, et al.
Identification of a Polymorphic Gene, BCL2A1, Encoding Two Novel Hematopoietic Lineage-specific Minor Histocompatibility Antigens
J. Exp. Med.,
June 2, 2003;
197(11):
1489 - 1500.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Murata, E. H. Warren, and S. R. Riddell
A Human Minor Histocompatibility Antigen Resulting from Differential Expression due to a Gene Deletion
J. Exp. Med.,
May 19, 2003;
197(10):
1279 - 1289.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Orsini, R. Bellucci, E. P. Alyea, R. Schlossman, C. Canning, S. McLaughlin, P. Ghia, K. C. Anderson, and J. Ritz
Expansion of Tumor-specific CD8+ T Cell Clones in Patients with Relapsed Myeloma after Donor Lymphocyte Infusion
Cancer Res.,
May 15, 2003;
63(10):
2561 - 2568.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Sahara and N. Shastri
Second Class Minors: Molecular Identification of the Autosomal H46 Histocompatibility Locus as a Peptide Presented by Major Histocompatibility Complex Class II Molecules
J. Exp. Med.,
February 3, 2003;
197(3):
375 - 385.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
